XM does not provide services to residents of the United States of America.

London's FTSE 100 falls after Labour's first budget



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-London's FTSE 100 falls after Labour's first budget</title></head><body>

UK budget declares tax rise

AstraZeneca falls on China probe

GSK warns of lower 2024 vaccine sales, shares fall

FTSE 100 down 0.7%, FTSE up 250 up 0.3%

Updated at 1652 GMT

By Shubham Batra and Nikhil Sharma

Oct 30 (Reuters) -The UK's FTSE 100 fell to an over two-month low on Wednesday, dragged down by the healthcare sector, while midcap stocks got a lift even as the latest UK budget came with the biggest tax increases in three decades.

The blue-chip FTSE 100 .FTSE fell 0.7% to its lowest level since August 9, weighed down by AstraZeneca AZN.L and GSK GSK.L.

The midcap FTSE 250 .FTMC rose 0.3% as market players deemed the new Labour government's first UK budget to be less punitive on businesses than many had previously feared.

Small cap stocks got an even bigger boost. The FTSE AIM index .FTAI rose about 4%, logging its biggest one-day rally since April 2020.

Finance minister Rachel Reeves said she would raise taxes by 40 billion pounds ($52 billion) a year, much of it paid by businesses and the wealthy, and she blamed the Conservatives for leaving her Labour Party with a "black hole" in the budget.

"By 2029 fewer people will drift into higher tax bands now that thresholds will be uprated with inflation once again. This tax tweak, coupled with the rise in the minimum wage, will eventually put more money into consumers’ pockets," said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

Pub stocks enjoyed a lift after Reeves announced a cut to duties on alcoholic drinks in pubs, and extended England's business rates relief for retail and hospitality. Marstons MARS.L rose 3.4%.

Betting firm Entain ENT.L jumped 8.6% after Reeves left taxes on the sector unchanged.

AstraZeneca AZN.L fell 2.8% after the drugmaker said its China president is under investigation and is cooperating with Chinese authorities.

GSK GSK.L dropped 3% after the drugmaker warned that its vaccine sales would fall this year, after weaker-than-expected sales for its respiratory syncytial virus and shingles vaccines in the third quarter.

Spirits maker Diageo DGE.L fell 2.6% after its Italian peer Campari CPRI.MI tumbled on missing analysts' third-quarter earnings expectations.

In contrast, Standard Chartered STAN.L rose 4% on plans to double investment in its wealth unit while paring back retail banking, as it lifted performance targets and said it will go further in reshaping the bank to try and meet those goals.



Reporting by Shubham Batra in Bengaluru; Editing by Rashmi Aich, William Maclean

 For related prices, Reuters users may click on - * UK stock report .L FTSE index: 0#.FTS6 techMARK 100 index: .FTT1X FTSE futures: 0#FFI: Gilt futures: 0#FLG: Smallcap index: .FTSC FTSE 250 index: .FTMC FTSE 350 index: .FTLC Market digest: .AD.L Top 10 by vol: .AV.L Top price gainers: .NG.L Top % gainers: .PG.L Top price losers: .NL.L Top % losers: .PL.L * For related news, click on - * UK hot stocks: HOT and GB Wall Street: .N Gilts report: GB/ Euro bond report GVD/EUR Pan European stock report: .EU Tokyo stocks: .T HK stocks: .HK Sterling report: GBP/ Dollar report: USD/ * For company prices, click on - * Company directory: UKEQ By sector: FTAX * For pan-European market data, click on - * European Equities speed guide................ EUR/EQUITY FTSE Eurotop 300 index........................... .FTEU3 DJ STOXX index................................... .STOXX Top 10 STOXX sectors........................ .PGL.STOXXS Top 10 EUROSTOXX sectors................... .PGL.STOXXES Top 10 Eurotop 300 sectors.................. .PGL.FTEU3S Top 25 European pct gainers.................... .PG.PEUR Top 25 European pct losers..................... .PL.PEUR
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.